Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice Melinda J. GooderhamAndrew E. PinkMelissa Watkins Review Open access 23 July 2023 Pages: 1893 - 1907
Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management Xiaoyan ZhangYao XieLin Wang Review Open access 01 August 2023 Pages: 1909 - 1934
Reinforcing Photoprotection for Skin of Color: A Narrative Review Jerry TsaiAnna L. Chien Review Open access 26 July 2023 Pages: 1935 - 1958
Recommendations for Cost-Conscious Treatment of Basal Cell Carcinoma Palak V. PatelJessica N. PixleySteven R. Feldman Review Open access 02 August 2023 Pages: 1959 - 1971
Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic Ashis K. DasEunice ChangMyriam Cordey Original Research Open access 01 July 2023 Pages: 1973 - 1984
Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic Ashis K. DasEunice ChangMyriam Cordey Correction Open access 23 July 2023 Pages: 1985 - 1985
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years Elaine C. SiegfriedEric L. SimpsonAinara Rodríguez Marco Original Research Open access 22 July 2023 Pages: 1987 - 2000
Patient Experience of Lichen Planus: A Qualitative Exploration of Signs, Symptoms, and Health-Related Quality of Life Impacts Aoife Mahon-SmithMolly CliffordSantiago G. Moreno Original Research Open access 28 July 2023 Pages: 2001 - 2017
Early Discontinuation of Apremilast in Patients with Psoriasis and Gastrointestinal Comorbidities: Rates and Associated Risk Factors Lana SchmidtChing An WangLauren Seigel Original Research Open access 30 July 2023 Pages: 2019 - 2030
Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies Linda Stein GoldAndreas PinterAdam Reich Original Research Open access 25 July 2023 Pages: 2031 - 2044
Racial and Ethnic Differences in Sociodemographic, Clinical, and Treatment Characteristics Among Patients with Atopic Dermatitis in the United States and Canada: Real-World Data from the CorEvitas Atopic Dermatitis Registry Jonathan I. SilverbergVivian Y. ShiEric Simpson Original Research Open access 22 July 2023 Pages: 2045 - 2061
Basal Cell Carcinoma After High Dose Rate Brachytherapy: Medium-term Dermoscopic Evaluation of Cancer’s Response Tomasz KrzysztofiakMagdalena SuchorzepkaGrażyna Kamińska-Winciorek Original Research Open access 09 August 2023 Pages: 2063 - 2078
Real-World Treatment Patterns in Patients with Vitiligo in the United States David RosmarinAhmed M. SolimanChao Li Original Research Open access 07 August 2023 Pages: 2079 - 2091
The Prevalent Comorbidome at the Onset of Psoriasis Diagnosis Alessandra BujaAndrea MiattonGiovanni Damiani Original Research Open access 05 August 2023 Pages: 2093 - 2105
Long-Term Effectiveness of Dupilumab in Patients with Atopic Dermatitis: Results up to 3 Years from the RELIEVE-AD Study Alexa B. KimballDimittri DelevryBruce Strober Brief Report Open access 08 August 2023 Pages: 2107 - 2120
The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area Alessia VillaniGabriella FabbrociniMassimiliano Scalvenzi Brief Report Open access 21 July 2023 Pages: 2121 - 2126
Correction to: The Needs of Patients with Psoriasis and Benefits of Apremilast in French Clinical Practice: Results from the Observational REALIZE Study Denis JullienMarie-Aleth RichardAnne Bouloc Correction Open access 08 July 2023 Pages: 2127 - 2127